{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:22:23Z","timestamp":1742012543602,"version":"3.38.0"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2024-11-4","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:32:29Z","timestamp":1741707149000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasis"],"prefix":"10.7573","volume":"14","author":[{"given":"Tiago","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mendes-Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jo\u00e3o","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2025,3,14]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2025\/03\/dic.2024-11-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:57:16Z","timestamp":1741957036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/real-world-experience-with-brodalumab-in-a-portuguese-cohort-of-patients-with-moderate-to-severe-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2024-11-4","relation":{},"ISSN":["1740-4398"],"issn-type":[{"type":"electronic","value":"1740-4398"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}